Scientific publications
GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
Mikel Rico 1 , Sonia Flamarique 2 , Cristina Casares 3 , Tamara García 4 , Miriam López 5 , Maribel Martínez 1 , Javier Serrano 6 , Manuel Blanco 7 , Raúl Hernanz 8 , Lourdes de Ingunza-Barón 9 , Francisco José Marcos 3 , Felipe Couñago 10
Abstract
Thymic epithelial tumours (TET) are rare, heterogeneous neoplasms that range from resectable indolent tumours to aggressive thymic carcinomas with a strong tendency to metastasize. The pathological diagnosis is complex, in part due to the existence of several different classification systems.
The evidence base for the management of TETs is scant and mainly based on non-randomised studies and retrospective series. Consequently, the clinical management of TETs tends to be highly heterogenous, which makes it difficult to improve the evidence level. The role of technological advances in the field of radiotherapy and new systemic therapies in the treatment of TETs has received little attention to date.
In the present clinical guidelines, developed by the GOECP/SEOR, we review recent developments in the diagnosis and classification of TETs. We also present a consensus-based therapeutic strategy for each disease stage that takes into consideration the best available evidence.
These guidelines focus primarily on the role of radiotherapy, including recent advances, in the management of TETs. The main aim of this document is to promote the standardisation of clinical practice and lay the foundations for future studies to clarify the main unresolved questions related to the optimal management of TET.
CITATION World J Clin Oncol. 2021 Apr 24;12(4):195-216. doi: 10.5306/wjco.v12.i4.195
Our authors
